Ebn Sina Medical, a subsidiary of Aamal Q.P.S.C. Strengthens Commitment to Healthcare Innovation through their continued partnership with Novo Nordisk to bring Wegovy® (Semaglutide 2.4mg) to Qatar

: Ebn Sina Medical, a subsidiary of Aamal Company Q.P.S.C. and a leading supplier of pharmaceutical, and Novo Nordisk, the Danish leading global healthcare company renowned for its expertise in treating chronic diseases such as diabetes and obesity, announced the availability of Wegovy® (Semaglutide 2.4mg) in Qatar.